Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2023 | May 01, 2023 | |
Document Information [Line Items] | ||
Entity Central Index Key | 0001065201 | |
Entity Registrant Name | AMERINST INSURANCE GROUP LTD | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2023 | |
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 000-28249 | |
Entity Incorporation, State or Country Code | D0 | |
Entity Tax Identification Number | 98-0207447 | |
Entity Address, Address Line One | 25 Church Street, Continental Building | |
Entity Address, City or Town | Hamilton | |
Entity Address, Country | BM | |
Entity Address, Postal Zip Code | HMGX | |
City Area Code | 441 | |
Local Phone Number | 295-2185 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 995,253 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
ASSETS | ||
Cash and cash equivalents | $ 1,973,811 | $ 2,414,077 |
Property and equipment (Note 2) | 568,996 | 644,133 |
Deferred income taxes | 151,000 | 232,000 |
Prepaid expenses and other assets (Note 3) | 992,582 | 792,245 |
TOTAL ASSETS | 3,686,389 | 4,082,455 |
LIABILITIES | ||
Accrued expenses and other liabilities (Note 4) | 2,338,582 | 2,346,805 |
TOTAL LIABILITIES | 2,338,582 | 2,346,805 |
COMMITMENTS AND CONTINGENCIES | ||
SHAREHOLDERS’ EQUITY | ||
Common shares, $1 par value, 2023 and 2022: 2,000,000 shares authorized, 995,253 issued and outstanding | 995,253 | 995,253 |
Additional paid-in-capital | 6,287,293 | 6,287,293 |
Retained earnings | 3,337,757 | 3,725,600 |
Shares held by Subsidiary (375,861 shares) at cost | (9,272,496) | (9,272,496) |
TOTAL SHAREHOLDERS’ EQUITY | 1,347,807 | 1,735,650 |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ 3,686,389 | $ 4,082,455 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares | Mar. 31, 2023 | Dec. 31, 2022 |
Common shares, par value (in dollars per share) | $ 1 | $ 1 |
Common shares, shares authorized (in shares) | 2,000,000 | 2,000,000 |
Common shares, issued (in shares) | 995,253 | 995,253 |
Common shares, outstanding (in shares) | 995,253 | 995,253 |
Shares held by Subsidiary (in shares) | 375,861 | 375,861 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
REVENUE | ||
Commission income | $ 629,367 | $ 777,506 |
Net investment income | 224 | 31 |
TOTAL REVENUE | 629,591 | 777,537 |
LOSSES AND EXPENSES | ||
Operating and management expenses | 936,434 | 1,005,798 |
TOTAL LOSSES AND EXPENSES | 936,434 | 1,005,798 |
NET LOSS BEFORE TAX | (306,843) | (228,261) |
Income tax expense | 81,000 | (18,000) |
NET LOSS AFTER TAX | (387,843) | (210,261) |
OTHER COMPREHENSIVE LOSS | ||
Net unrealized holding losses arising during the period | 0 | 0 |
OTHER COMPREHENSIVE LOSS | 0 | 0 |
COMPREHENSIVE LOSS | (387,843) | (210,261) |
RETAINED EARNINGS, BEGINNING OF PERIOD | 3,725,600 | 5,656,163 |
Net loss | (387,843) | (210,261) |
Dividends | 0 | 0 |
RETAINED EARNINGS, END OF PERIOD | $ 3,337,757 | $ 5,445,902 |
Net loss per share | ||
Basic (in dollars per share) | $ (0.63) | $ (0.34) |
Diluted (in dollars per share) | (0.63) | (0.34) |
Dividends (in dollars per share) | $ 0 | $ 0 |
Weighted average number of shares outstanding for the entire period | ||
Basic (in shares) | 619,392 | 619,392 |
Diluted (in shares) | 619,392 | 619,392 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | AOCI Attributable to Parent [Member] | Shares Held By Subsidiary [Member] | Total |
Balance (in shares) at Dec. 31, 2021 | 995,253 | |||||
Balance at Dec. 31, 2021 | $ 6,287,293 | $ 5,656,163 | $ 0 | $ (9,272,496) | $ 3,666,213 | |
Net loss | 0 | (210,261) | 0 | 0 | (210,261) | |
Unrealized (loss) on securities, net of reclassification adjustment | 0 | 0 | 0 | 0 | 0 | |
Unrealized (loss) on securities, net of reclassification adjustment | 0 | 0 | 0 | 0 | 0 | |
Balance (in shares) at Mar. 31, 2022 | 995,253 | |||||
Balance at Mar. 31, 2022 | 6,287,293 | 5,445,902 | 0 | (9,272,496) | 3,455,952 | |
Balance (in shares) at Dec. 31, 2022 | 995,253 | |||||
Balance at Dec. 31, 2022 | 6,287,293 | 3,725,600 | 0 | (9,272,496) | 1,735,650 | |
Net loss | 0 | (387,843) | 0 | 0 | (387,843) | |
Unrealized (loss) on securities, net of reclassification adjustment | 0 | 0 | 0 | 0 | 0 | |
Unrealized (loss) on securities, net of reclassification adjustment | 0 | 0 | 0 | 0 | 0 | |
Balance (in shares) at Mar. 31, 2023 | 995,253 | |||||
Balance at Mar. 31, 2023 | $ 6,287,293 | $ 3,337,757 | $ 0 | $ (9,272,496) | $ 1,347,807 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
OPERATING ACTIVITIES | ||
Net Cash used in Operating Activities | $ (436,778) | $ (801,516) |
INVESTING ACTIVITIES | ||
Purchases of property and equipment | (3,488) | (39,431) |
Net Cash used in by Investing Activities | (3,488) | (39,431) |
FINANCING ACTIVITIES | ||
Net Cash provided by Financing Activities | 0 | 0 |
NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (440,266) | (840,947) |
CASH, CASH EQUIVALENTS AND RESTRCITED CASH AT BEGINNING OF PERIOD | 2,414,077 | 3,477,714 |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | $ 1,973,811 | $ 2,636,767 |
Note 1 - Basis of Preparation a
Note 1 - Basis of Preparation and Consolidation | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | 1. The condensed consolidated financial statements included herein have been prepared by AmerInst Insurance Group, Ltd. (“AmerInst”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). These financial statements reflect all adjustments consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of our financial position and results of operations as of the end of and for the periods presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). All intercompany transactions and balances have been eliminated on consolidation. These statements are condensed and do not December 31, 2022 10 New Accounting Pronouncements New Accounting Standards Adopted in 2023 No 2023. Accounting Standards Not No not |
Note 2 - Property and Equipment
Note 2 - Property and Equipment | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | 2. Property and equipment, all associated with Protexure, at March 31, 2023 December 31, 2022 Cost Accumulated Depreciation and Amortization Total March 31, 2023 Furniture and fixtures $ 36,705 $ 35,520 $ 1,185 Office equipment 107,392 101,869 5,523 Computer equipment 24,129 22,760 1,369 Internal use software 1,872,952 1,312,033 560,919 Total $ 2,041,178 $ 1,472,182 $ 568,996 Cost Accumulated Depreciation and Amortization Total December 31, 2022 Furniture and fixtures $ 36,705 $ 35,284 $ 1,421 Office equipment 107,392 100,027 7,365 Computer equipment 24,129 22,532 1,597 Internal use software 1,869,464 1,235,714 633,750 Total $ 2,037,690 $ 1,393,558 $ 644,133 |
Note 3 - Prepaid Expenses and O
Note 3 - Prepaid Expenses and Other Assets | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Other Assets Disclosure [Text Block] | 3. Prepaid expenses and other assets as at March 31, 2023 December 31, 2022 2023 2022 Prepaid expenses and other assets 107,885 68,823 Accounts receivable 553,426 462,567 Policy acquisition costs 203,325 213,735 Building right of use asset 127,946 47,120 $ 992,582 $ 792,245 |
Note 4 - Accrued Expenses and O
Note 4 - Accrued Expenses and Other Liabilities | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Other Liabilities Disclosure [Text Block] | 4. Accrued expenses and other liabilities as at March 31, 2023 December 31, 2022 2023 2022 Premiums payable $ 1,628,573 $ 1,686,066 Accounts payable and accrued liabilities 376,843 361,497 Unearned commission income 95,793 138,222 Building lease liability 128,004 51,651 Other liabilities 109,369 109,369 $ 2,338,582 $ 2,346,805 |
Note 5 - Investments
Note 5 - Investments | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] | 5. Major categories of net investment income during the three March 31, 2023 2022 March 31, 2023 March 31, 2022 Interest earned: Short term investments and cash and cash equivalents $ 224 $ 31 Net investment income $ 224 $ 31 |
Note 6 - Segment Information
Note 6 - Segment Information | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Segment Reporting Disclosure [Text Block] | 6. AmerInst has two 1 2 three March 31, 2023 2022. As of and for the Three Months Ended March 31, 2023 Corporate Segment Insurance Segment Total Revenues $ 224 $ 629,367 $ 629,591 Total expenses 126,989 890,445 1,017,434 Segment loss (126,765 ) (261,078 ) (387,843 ) Identifiable assets — 568,996 568,996 As of and for the Three Months Ended March 31, 2022 Corporate Segment Insurance Segment Total Revenues $ 29 $ 777,505 $ 777,537 Total expenses 171,402 816,396 987,798 Segment loss (171,373 ) (38,888 ) (210,261 ) Identifiable assets — 848,547 848,547 |
Note 7 - Stock Compensation
Note 7 - Stock Compensation | 3 Months Ended |
Mar. 31, 2023 | |
Notes to Financial Statements | |
Share-Based Payment Arrangement [Text Block] | 7. Phantom Shares: Protexure has employment agreements with two may For these two January 1, 2015. The liability relating to these phantom shares is recalculated quarterly based on the net book value of our common shares at the end of each quarter. As a result of the overall decrease in the net book value of our common shares since the grant dates, we have not March 31, 2023. Stock Option Plan: The Company has a nonqualified stock option plan to advance the development, growth and financial condition of the Company. This plan provides incentives through participation in the appreciation of its common stock in order to secure, retain and motivate directors and employees and align such person’s interests with those of its shareholders. A total of 100,000 shares are authorized under the stock option plan. A summary of the status of the stock option plan as of March 31, 2023 Vested Shares Weighted Average Exercise Price Per Share Non-vested Shares Weighted Average Exercise Price Per Share Total Shares Weighted Average Exercise Price Per Share Outstanding January 1, 2023 43,100 $ 28.45 1,900 $ 30.46 45,000 $ 28.54 Granted — — — — — — Forfeited (35,000 ) 27.99 — — (35,000 ) 27.99 Exercised — — — — — — Vested 1,400 30.58 (1,400 ) 30.58 — — Outstanding March 31, 2023 9,500 $ 30.46 500 $ 30.14 10,000 $ 30.45 Options exercisable at year end — — — — — — Weighted average fair value of options per share granted during the year — — — — — — Remaining contractual life (years) 1.0 1.5 1.0 A summary of the status of the stock option plan as of December 31, 2022 Vested Shares Weighted Average Exercise Price Per Share Non-vested Shares Weighted Average Exercise Price Per Share Total Shares Weighted Average Exercise Price Per Share Outstanding January 1, 2022 34,200 $ 28.43 10,800 $ 28.86 45,000 $ 28.54 Granted — — — — — — Forfeited — — — — — — Exercised — — — — — — Vested 8,900 28.52 (8,900 ) 28.52 — — Outstanding December 31, 2022 43,100 $ 28.45 1,900 $ 30.46 45,000 $ 28.54 Options exercisable at year end — — — — — — Weighted average fair value of options per share granted during the year — — — — — — Remaining contractual life (years) 0.2 1.2 0.3 The Company accounts for these options in accordance with U.S. GAAP, which requires that the fair value of the equity awards be recognized as compensation expense over the period during which the employee is required to provide service in exchange for such an award. The Company is amortizing compensation expense over the vesting period, or five three March 31, 2023 2022, |
Note 2 - Property and Equipme_2
Note 2 - Property and Equipment (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | Cost Accumulated Depreciation and Amortization Total March 31, 2023 Furniture and fixtures $ 36,705 $ 35,520 $ 1,185 Office equipment 107,392 101,869 5,523 Computer equipment 24,129 22,760 1,369 Internal use software 1,872,952 1,312,033 560,919 Total $ 2,041,178 $ 1,472,182 $ 568,996 Cost Accumulated Depreciation and Amortization Total December 31, 2022 Furniture and fixtures $ 36,705 $ 35,284 $ 1,421 Office equipment 107,392 100,027 7,365 Computer equipment 24,129 22,532 1,597 Internal use software 1,869,464 1,235,714 633,750 Total $ 2,037,690 $ 1,393,558 $ 644,133 |
Note 3 - Prepaid Expenses and_2
Note 3 - Prepaid Expenses and Other Assets (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] | 2023 2022 Prepaid expenses and other assets 107,885 68,823 Accounts receivable 553,426 462,567 Policy acquisition costs 203,325 213,735 Building right of use asset 127,946 47,120 $ 992,582 $ 792,245 |
Note 4 - Accrued Expenses and_2
Note 4 - Accrued Expenses and Other Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Other Liabilities [Table Text Block] | 2023 2022 Premiums payable $ 1,628,573 $ 1,686,066 Accounts payable and accrued liabilities 376,843 361,497 Unearned commission income 95,793 138,222 Building lease liability 128,004 51,651 Other liabilities 109,369 109,369 $ 2,338,582 $ 2,346,805 |
Note 5 - Investments (Tables)
Note 5 - Investments (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Condensed Cash Flow Statement [Table Text Block] | March 31, 2023 March 31, 2022 Interest earned: Short term investments and cash and cash equivalents $ 224 $ 31 Net investment income $ 224 $ 31 |
Note 6 - Segment Information (T
Note 6 - Segment Information (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Schedule of Segment Reporting Information, by Segment [Table Text Block] | As of and for the Three Months Ended March 31, 2023 Corporate Segment Insurance Segment Total Revenues $ 224 $ 629,367 $ 629,591 Total expenses 126,989 890,445 1,017,434 Segment loss (126,765 ) (261,078 ) (387,843 ) Identifiable assets — 568,996 568,996 As of and for the Three Months Ended March 31, 2022 Corporate Segment Insurance Segment Total Revenues $ 29 $ 777,505 $ 777,537 Total expenses 171,402 816,396 987,798 Segment loss (171,373 ) (38,888 ) (210,261 ) Identifiable assets — 848,547 848,547 |
Note 7 - Stock Compensation (Ta
Note 7 - Stock Compensation (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Tables | |
Share-Based Payment Arrangement, Option, Activity [Table Text Block] | Vested Shares Weighted Average Exercise Price Per Share Non-vested Shares Weighted Average Exercise Price Per Share Total Shares Weighted Average Exercise Price Per Share Outstanding January 1, 2023 43,100 $ 28.45 1,900 $ 30.46 45,000 $ 28.54 Granted — — — — — — Forfeited (35,000 ) 27.99 — — (35,000 ) 27.99 Exercised — — — — — — Vested 1,400 30.58 (1,400 ) 30.58 — — Outstanding March 31, 2023 9,500 $ 30.46 500 $ 30.14 10,000 $ 30.45 Options exercisable at year end — — — — — — Weighted average fair value of options per share granted during the year — — — — — — Remaining contractual life (years) 1.0 1.5 1.0 Vested Shares Weighted Average Exercise Price Per Share Non-vested Shares Weighted Average Exercise Price Per Share Total Shares Weighted Average Exercise Price Per Share Outstanding January 1, 2022 34,200 $ 28.43 10,800 $ 28.86 45,000 $ 28.54 Granted — — — — — — Forfeited — — — — — — Exercised — — — — — — Vested 8,900 28.52 (8,900 ) 28.52 — — Outstanding December 31, 2022 43,100 $ 28.45 1,900 $ 30.46 45,000 $ 28.54 Options exercisable at year end — — — — — — Weighted average fair value of options per share granted during the year — — — — — — Remaining contractual life (years) 0.2 1.2 0.3 |
Note 2 - Property and Equipme_3
Note 2 - Property and Equipment (Details Textual) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 |
Property, Plant and Equipment, Net | $ 568,996 | $ 644,133 | $ 848,547 |
Note 2 - Property and Equipme_4
Note 2 - Property and Equipment - Property and Equipment (Details) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 |
Cost | $ 2,041,178 | $ 2,037,690 | |
Amortization | 1,472,182 | 1,393,558 | |
Property and equipment (Note 2) | 568,996 | 644,133 | $ 848,547 |
Furniture and Fixtures [Member] | |||
Cost | 36,705 | 36,705 | |
Amortization | 35,520 | 35,284 | |
Property and equipment (Note 2) | 1,185 | 1,421 | |
Office Equipment [Member] | |||
Cost | 107,392 | 107,392 | |
Amortization | 101,869 | 100,027 | |
Property and equipment (Note 2) | 5,523 | 7,365 | |
Computer Equipment [Member] | |||
Cost | 24,129 | 24,129 | |
Amortization | 22,760 | 22,532 | |
Property and equipment (Note 2) | 1,369 | 1,597 | |
Software Development [Member] | |||
Cost | 1,872,952 | 1,869,464 | |
Amortization | 1,312,033 | 1,235,714 | |
Property and equipment (Note 2) | $ 560,919 | $ 633,750 |
Note 3 - Prepaid Expenses and_3
Note 3 - Prepaid Expenses and Other Assets - Prepaid Expenses (Details) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 |
Prepaid expenses and other assets | $ 107,885 | $ 68,823 | |
Accounts receivable | 553,426 | 462,567 | |
Policy acquisition costs | 203,325 | 213,735 | |
Prepaid Expense and Other Assets | 992,582 | $ 792,245 | 792,245 |
Prepaid Expenses and Other Assets [Member] | |||
Building right of use asset | $ 127,946 | $ 47,120 |
Note 4 - Accrued Expenses and_3
Note 4 - Accrued Expenses and Other Liabilities - Accrued Expenses and Other Liabilities (Details) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 |
Premiums payable | $ 1,628,573 | $ 1,686,066 | |
Accounts payable and accrued liabilities | 376,843 | 361,497 | |
Unearned commission income | 95,793 | 138,222 | |
Other liabilities | 109,369 | 109,369 | |
Accounts Payable and Accrued Liabilities | 2,338,582 | $ 2,346,805 | 2,346,805 |
Accrued Expenses and Other Liabilities [Member] | |||
Building lease liability | $ 128,004 | $ 51,651 |
Note 5 - Investments - Major Ca
Note 5 - Investments - Major Categories of Net Interest and Dividend Income (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Short term investments and cash and cash equivalents | $ 224 | $ 31 |
Net investment income | $ 224 | $ 31 |
Note 6 - Segment Information (D
Note 6 - Segment Information (Details Textual) | 3 Months Ended |
Mar. 31, 2023 | |
Number of Reportable Segments | 2 |
Note 6 - Segment Information -
Note 6 - Segment Information - Segment Reporting Information (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Revenues | $ 629,591 | $ 777,537 | |
Total expenses | 1,017,434 | 987,798 | |
Segment loss | (387,843) | (210,261) | |
Property, Plant and Equipment, Net | 568,996 | 848,547 | $ 644,133 |
Reinsurance Segment [Member] | |||
Revenues | 224 | 29 | |
Total expenses | 126,989 | 171,402 | |
Segment loss | (126,765) | (171,373) | |
Property, Plant and Equipment, Net | 0 | 0 | |
Insurance Segment [Member] | |||
Revenues | 629,367 | 777,505 | |
Total expenses | 890,445 | 816,396 | |
Segment loss | (261,078) | (38,888) | |
Property, Plant and Equipment, Net | $ 568,996 | $ 848,547 |
Note 7 - Stock Compensation (De
Note 7 - Stock Compensation (Details Textual) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Phantom Share Units (PSUs) [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | 48,762 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | 0 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Value, Payable Requisite Employee Age (Year) | 65 years | |
Share-Based Payment Arrangement, Option [Member] | ||
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | 100,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period (Year) | 5 years | |
Share-Based Payment Arrangement, Expense | $ 0 | $ 0 |
Note 7 - Stock Compensation - S
Note 7 - Stock Compensation - Summary of the Status of the Stock Option Plan (Details) - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Balance, vested (in shares) | 43,100 | 34,200 |
Balance, weighted average exercise price per share (in dollars per share) | $ 28.45 | $ 28.43 |
Balance, non-vested shares (in shares) | 1,900 | 10,800 |
Balance, weighted average exercise price per share, non-vested (in dollars per share) | $ 30.46 | $ 28.86 |
Balance (in shares) | 45,000 | 45,000 |
Balance, weighted average exercise price (in dollars per share) | $ 28.54 | $ 28.54 |
Granted, vested (in shares) | 0 | 0 |
Granted, weighted average exercise price per share (in dollars per share) | $ 0 | $ 0 |
Granted, weighted average exercise price (in dollars per share) | $ 0 | |
Forfeited, vested (in shares) | (35,000) | |
Forfeited, weighted average exercise price (in dollars per share) | $ 27.99 | |
Forfeited, non-vested shares (in shares) | 0 | 0 |
Forfeited, weighted average exercise price per share, non-vested (in dollars per share) | $ 0 | $ 0 |
Exercised, vested (in shares) | 0 | |
Exercised, weighted average exercise price per share (in dollars per share) | $ 0 | |
Exercised, vested (in shares) | 0 | |
Vested, vested (in shares) | 1,400 | 8,900 |
Vested, weighted average exercise price per share (in dollars per share) | $ 30.58 | $ 28.52 |
Vested, non-vested shares (in shares) | (1,400) | (8,900) |
Vested, weighted average exercise price per share, non-vested (in dollars per share) | $ 30.58 | $ 28.52 |
Balance, vested (in shares) | 9,500 | 43,100 |
Balance, weighted average exercise price per share (in dollars per share) | $ 30.46 | $ 28.45 |
Balance, non-vested shares (in shares) | 500 | 1,900 |
Balance, weighted average exercise price per share, non-vested (in dollars per share) | $ 30.14 | $ 30.46 |
Balance (in shares) | 10,000 | 45,000 |
Balance, weighted average exercise price (in dollars per share) | $ 30.45 | $ 28.54 |
Options exercisable at year end, vested (in shares) | 0 | |
Options exercisable at year end, weighted average exercise price per share, vested (in dollars per share) | $ 0 | |
Options exercisable at year end (in shares) | 0 | |
Remaining contractual life (years), vested (Year) | 1 year | 2 months 12 days |
Remaining contractual life (years), non-vested shares (Year) | 1 year 6 months | 1 year 2 months 12 days |
Remaining contractual life (years), outstanding shares (Year) | 1 year | 3 months 18 days |